Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients

NCT06301386 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Everolimus
DRUG: PD-1

Sponsor

Fudan University

Collaborators

[object Object]